SKB Names U'Prichard to Head Worldwide R&D, Succeeding George Poste | GenomeWeb

LONDON--After a six-month search, SmithKline Beecham has named David U'Prichard to head the international pharmaceutical giant's research and development operations, succeeding George Poste, who is now the company's chief science and technology officer. U'Prichard came from Zeneca Group, where he had been head of international research for the pharmaceutical company since 1994. He will report to Jean-Pierre Garnier, COO and head of SmithKline's pharmaceutical division.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.